Anthony Stephan on radio talking about newest EMPowerplus research

Would you consider a 47.6% outcome for a study on mood disorders significant? What would you say if this published study was on a micronutrient supplement and not a drug?

Last week, a ground-breaking study published in the British Medical Journal cited that researchers at the University of Canterbury in NZ found the micronutrient supplement Truehope EMPowerplus had significant benefits for adults with psychiatric symptoms of ADHD, depression, hyperactivity, impulsivity and inattention. The research publication also identified a major reduction in symptoms in those suffering from ‘moderate’ to ‘severe’ depression.

Truehope founder, Anthony Stephan believes that this research places EMPowerplus in a new class of first line treatments for the most common mood disorders. The safety profile of the product has been researched extensively and has been proven safe in use over the past 16 years. EMPowerplus has now been the subject of 24 clinical studies.

Recently, Anthony appeared on the Holy Hormones Honey! radio show to discuss the new study and the implications it has for Truehope, as well as the mental health care industry in general.

Listen to the interview now!

 

Continued

Categories:

First double blind, placebo study published on Truehope EMPowerplus

You asked for it, and here it is: the first double-blind, randomized, and placebo-controlled trial to be published on Truehope EMpowerplus.

New Zealand researchers published today an article in the British Journal of Psychiatry a paper that outlines their investigation into the efficacy and safety of EMPowerplus in the treatment of ADHD in adults.

Continued

Categories:

EMPowerplus and olive leaf extract to treat ADHD and depression

A New Zealand researcher recently published a case study in the Advances in Mind-Body Medicine journal regarding the effect EMPowerplus and olive leaf extract have together on ADHD and depression.

A 24-year-old woman participated in a 2010 study that measured the effect of EMPowerplus on people with ADHD following an earthquake in New Zealand. After 8 weeks on EMPowerplus, the woman “was no longer depressed, and her ADHD scores had fallen to within the normal-average range.” She maintained these results for the 4-month follow-up period,

Continued

Categories:

The effect of EMPowerplus on cannabis and nicotine abuse

New Zealand researchers recently published a case study paper in the Journal of Psychoactive Drugs regarding the effect of EMPowerplus on cannabis and nicotine abuse.

The case study involved a 20-year-old man who met DSM-IV criteria for ADHD combined type, major depressive disorder, panic disorder with agoraphobia, and substance abuse. Brian used cigarettes and cannabis daily and had been on medications for his psychiatric symptoms (including methylphenidate, imipramine, fluoxetine, clonidine, amitriptyline, lorazepam, and clonazepam).

Continued

Categories:

Ashley’s success story: bipolar

Ashley first got ill in 2003 or 2004. She was prescribed medications, which she experienced severe side effects from. When Ashley brought up her issues and concerns with her doctor, she was told that this was normal and that she had nothing to worry about.

As time went on, the issues and side effects became more severe, and she was eventually admitted into the psych ward. Ashley stayed in the hospital for 3.5 months, where she was put on medication after medication, all with no success.

Continued

Categories:
Promo Fridays

Truehope Newsletter

Get special discounts every other week

Who doesn't like discounts??

Sign up to our biweekly newsletter now to receive a special discount codes and take advantage of some great savings on Truehope's life-changing products!

Truehope’s 3-step transition program

For the Truehope participants who wish to transition from medication to EMPowerplus for their mental health, we offer a three-step program: transition, support, refinement.

Continued

Categories:

Malnutrition and Obesity in Children With ADHD

Earlier this year, Turkish researchers published a study into the connection between malnutrition, obesity, and ADHD.

“Malnutrition and Obesity in Children With ADHD” was published in Journal of Attention Disorders. In it, the researchers studied over 360 children between 5 and 15 years of age who had attention deficit hyperactivity disorder, comparing them to nearly 400 children matched for age and sex (control group).

Continued

Categories:

Can micronutrients help ADHD?

Last month, researchers in Puerto Rico and the United States published a paper in Functional Foods in Health and Disease on the influence diet has on people with attention deficit-hyperactivity disorder.

The researchers tested 116 patients (ranging in age from 2–25 years old) who had a diagnosis of ADHD. They followed them from 3 months–3 years, comparing the distribution of fatty acids, essential metals, and the levels of metabolic stress factors.

Continued

Categories:

B-vitamin intake associated with mental health

Earlier this month, researchers at the University of Western Australia published an article in Preventive Medicine regarding the connection between adolescent mental health and low B-vitamin intake.

Researchers analyzed a year’s diet of 835 17-year-old participants specifically for relative vitamin B intake. They also used the Youth Self Report to assess mental health and behaviour. What they found was an apparent association between vitamin B intake and emotional or mental health problems.

Continued

Categories:

Nutrient Intake and ADHD

Last summer, the Journal of Attention Disorders published a study examining the relationship between dietary patterns and ADHD.

After examining 1172 adolescents with an ADHD diagnosis, researchers identified two major dietary patterns in the sample: western and healthy. The western dietary pattern included higher intakes of total fat, saturated fat, refined sugars, and sodium, and lower intakes of omega-3 fatty acids, fibre, and folate. The healthy dietary pattern had higher levels of omega-3 fatty acids,

Continued

Categories: